TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
TYK Medicines, Inc. Class H ( (HK:2410) ) just unveiled an announcement.
TYK Medicines, Inc, a company listed on the Hong Kong Stock Exchange, has announced a non-compliance incident involving one of its non-executive directors, Dr. Gu Eric Hong. Dr. Gu’s company, Pivot Pharma Tech (Shanghai) Co., Ltd., sold 10,000 H shares during a black-out period without prior notification to the company, reducing his shareholding from 2.20% to 2.19%. The company has responded by reminding its directors and senior management of compliance requirements and plans to provide regular training to prevent future incidents.
The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.
More about TYK Medicines, Inc. Class H
Average Trading Volume: 5,192,985
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$7.07B
See more insights into 2410 stock on TipRanks’ Stock Analysis page.